Natera (NTRA): Signatera Momentum Strengthens Growth Outlook
Fred Alger Management, an investment management company, released its third-quarter 2026 investor letter for “Alger Capital Appreciation Fund.” The letter can be downloaded here.
Natera Inc. (NTRA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 227,444 | $94,004,880 | -11% | 2.15% |
| 2. | Aubrey Capital Management Andrew Dalrymple And Barry Mccorkell | 8,400 | $3,474,198 | -48% | 3.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.56 | 19,011 | $562,054.51 | 420,000 | 2022-05-12 | Filing | |
| $28.81 | 159,783 | $4,603,348.23 | 400,989 | 2022-05-12 | Filing | |
| $28.09 | 41,026 | $1,152,358.80 | 241,026 | 2022-05-12 | Filing | |
| $33.49 | 40,695 | $1,362,798.23 | 1,291,584 | 2022-03-16 | Filing | |
| $32.59 | 85,903 | $2,799,982.51 | 1,250,889 | 2022-03-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $426.34 | 187 | $79,725.65 | 217,686 | 2026-10-28 | Filing | |
| $406.00 | 291 | $118,146.00 | 217,873 | 2026-10-27 | Filing | |
| $406.00 | 1,718 | $697,508.00 | 2,117,676 | 2026-10-27 | Filing | |
| $426.34 | 968 | $412,697.51 | 168,221 | 2026-10-28 | Filing | |
| $406.00 | 884 | $358,904.00 | 169,189 | 2026-10-27 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 531,443 | $219,650,706 | 0.13% | |
| 2. | 223,309 | $92,295,842 | 0.11% | |
| 3. | 201,333 | $83,212,942 | 0.73% | |
| 4. | 156,996 | $64,888,017 | 0.06% | |
| 5. | 91,154 | $37,674,860 | 0.77% |
News See All
Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?
Testing Volume Is Growing Faster Than the Valuation Can Ignore Natera, Inc.
11 Best Cancer Stocks to Invest In Now
Cancer’s Burden Keeps the Search for Better Treatments Urgent For cancer patients, progress means more time, fewer side effects, and a better chance of recovery.
3 Overlooked Vanguard ETFs with 30%+ Upside
With investors looking for growth opportunities, Vanguard ETFs offer a way to pursue meaningful upside while spreading exposure across dozens or ev...
Jim Cramer Calls Natera (NTRA) “a Promising Story”
Natera, Inc. (NASDAQ:NTRA) is expanding across oncology, women’s health and organ transplantation, but Jim Cramer says the stock’s valuation has become difficult to justify after a sharp rally.
10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds
In this article, we will discuss: 10 Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds.
12 Best Growth Stocks Trading in Oversold Territory
In this article, we will discuss the 12 Best Growth Stocks Trading in Oversold Territory.
8 Best Genomics Stocks to Buy According to Analysts
In this article, we will discuss: 8 Best Genomics Stocks to Buy According to Analysts.
Top 10 Stock Picks of 10 Famous Billionaires
In this article, we will discuss the 10 Top Stock Picks of 10 Famous Billionaire Investors. Smart money is back in the spotlight as hedge funds attract strong inflows and post solid returns.
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller
In this article, we will discuss the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller.
Hedge Fund Resource Center